Clinical Trial Update: Intravenous Ascorbic Acid in Women Receiving Adjuvant or Neo-Adjuvant Chemotherapy for Early Stage Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 study of intravenous ascorbic acid in women receiving adjuvant or neoadjuvant chemotherapy for early-stage breast cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Intravenous ascorbic acid (ascorbic acid)

Snippet

Sponsor: Midwestern Regional Medical Center | Conditions: Fatigue | Phase 2 | Status: WITHDRAWN